Search

Author/Creator Junming, Z.

1. First-in-human safety, pharmacokinetics, and preliminary efficacy of TPX-0022, a novel inhibitor of MET/SRC/CSF1R in patients with advanced solid tumors harboring genetic alterations in MET. (October 2020)

Authors:
Hong, D.; Bazhenova, L.; Cho, B.C.; Sen, S.; Ponz-Sarvise, M.; Heist, R.; Zimmerman, Z.; Le, X.; Xuan, D.; Junming, Z.; Lee, J.
Journal:
European journal of cancer
Issue:
Volume 138(2020)Supplement 2
Page Start:
S1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search